The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Researchers at Colorado State University (CSU) showed that exposure to riboflavin and ultraviolet light (R + UV) can reduce SARS-CoV-2 infectivity in human plasma and whole-blood products while maintaining blood product quality.
The CSU team aimed to determine whether it would be possible to kill the virus in blood products. Although scientists do not yet know if SARS-CoV-2 can be transmitted by blood transfusion, viral RNA has been detected in serum.
Researcher Izabela Ragan, postdoctoral fellow in the Department of Biomedical Sciences at Colorado State University. Courtesy of Ron Bend/CSU.
The research team treated nine plasma and three whole-blood products using an existing pathogen reduction technology system from Terumo…